These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate. Brown WA; Silver MA J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204 [TBL] [Abstract][Full Text] [Related]
4. Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite. Melkersson KI Hum Psychopharmacol; 2006 Dec; 21(8):529-32. PubMed ID: 17094165 [TBL] [Abstract][Full Text] [Related]
6. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of neuroleptic in patients receiving depot fluphenazine. Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997 [TBL] [Abstract][Full Text] [Related]
8. The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients. Lee BH; Kim YK Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):658-62. PubMed ID: 16466670 [TBL] [Abstract][Full Text] [Related]
9. The use of depot neuroleptics: clinical experience in the United States. Kane JM J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987 [TBL] [Abstract][Full Text] [Related]
10. Serum prolactin levels after a single and subchronic oral administration of chlorpromazine and sulpiride. A cross-over study in healthy volunteers. Männistö PT; Korttila K; Seppälä T Arzneimittelforschung; 1978; 28(1):76-8. PubMed ID: 580204 [TBL] [Abstract][Full Text] [Related]
11. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls. Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710 [TBL] [Abstract][Full Text] [Related]
12. Altered diurnal rhythm of prolactin in systemic sclerosis. Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228 [TBL] [Abstract][Full Text] [Related]
13. Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders. Eberhard J; Lindström E; Holstad M; Levander S Acta Psychiatr Scand; 2007 Apr; 115(4):268-76. PubMed ID: 17355517 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine. Marder SR; Van Putten T; Aravagiri M; Hubbard JW; Hawes EM; McKay G; Midha KK Psychopharmacol Bull; 1989; 25(3):479-82. PubMed ID: 2626520 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study. Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment. Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201 [TBL] [Abstract][Full Text] [Related]
17. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome. Turbott J; Villiger J; Hunter L Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
19. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650 [TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]